Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Interleukin Genetics (ILI)

Interleukin Genetics,
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ILI
DateTimeSourceHeadlineSymbolCompany
12/08/201021:07Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:ILIInterleukin Genetics,
05/08/201021:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:ILIInterleukin Genetics,
05/08/201013:49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ILIInterleukin Genetics,
05/08/201012:02Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
21/07/201021:30Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
25/06/201022:06Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
21/06/201011:31Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
13/05/201021:06Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:ILIInterleukin Genetics,
05/05/201011:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ILIInterleukin Genetics,
01/05/201000:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
01/05/201000:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ILIInterleukin Genetics,
30/04/201021:36Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
30/04/201018:15Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:ILIInterleukin Genetics,
13/04/201022:04Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)AMEX:ILIInterleukin Genetics,
08/04/201021:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
08/04/201021:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
05/04/201021:35Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)AMEX:ILIInterleukin Genetics,
01/04/201021:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
25/03/201020:13Edgar (US Regulatory)Annual Report (10-K)AMEX:ILIInterleukin Genetics,
19/03/201020:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
10/03/201022:11Edgar (US Regulatory)Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)AMEX:ILIInterleukin Genetics,
09/03/201014:46Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:ILIInterleukin Genetics,
05/03/201019:52Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)AMEX:ILIInterleukin Genetics,
03/03/201019:04Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
01/03/201022:00Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
19/02/201022:03Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:ILIInterleukin Genetics,
04/02/201012:00PR Newswire (US)Interleukin Genetics to Present at the 12th Annual BIO CEO ConferenceLSE:ILI
03/02/201021:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:ILIInterleukin Genetics,
02/02/201022:01Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
25/01/201021:17Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
 Showing the most relevant articles for your search:AMEX:ILI